How are drugs approved? Part 3. The stages of drug development

Journal of Psychosocial Nursing and Mental Health Services

Volumn 46, Issue 3, 2008, Pages 17-20

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DRUG APPROVAL; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HUMAN; ORGANIZATION; ORGANIZATION AND MANAGEMENT; REVIEW; SAFETY; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; HUMANS; ORGANIZATIONAL OBJECTIVES; SAFETY MANAGEMENT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 44049099017     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20080301-06     Document Type: Article

References (12)

1. Hirschfeld, S. (2004). The pediatric research equity act and oncology. Pediatric Blood & Cancer, 43, 99-102.
2. Khan, A.Y., Preskorn, S.H., & Baker, B. (2005). Effect of study criteria on recruitment and generalizability of the results. Journal of Clinical Psychopharmacology, 25, 271-275.
3. Lipsky, M.S., & Sharp, L.K. (2001). From idea to market: The drug approval process. Journal of the American Board of Family Practice, 14, 362-367.
4. Miller, P. (2005). Role of pharmacoeconomic analysis in R&D decision making: When, where, how? PharmacoEconomics, 23, 1-12.
5. Preskorn, S.H. (2002). Drug approvals and withdrawals over the last 60 years. Journal of Psychiatric Practice, 8, 41-50.
6. Rivas-Vazquez, R.A., & Mendez, C.I. (2002). Overview of the drug approval process. Professional Psychology, Research and Practice, 33, 502-506.
7. Roden, D.M., & Temple, R. (2005). The U.S. Food and Drug Administration cardiorenal advisory panel and the drug approval process. Circulation, 111, 1697-1702.
8. San Miguel, M.T., & Vargas, E. (2006). Drug evaluation and approval ptocess in the European Union. Arthritis and Rheumatism, 55, 12-14.
9. Schultz, W.B. (2007). Bolstering the FDA's drug-safety authority. New England Journal of Medicine, 357, 2217-2219.
10. Sharfstein, J.M., North, M., & Serwint, J.R. (2007). Over the counter but no longer under the radar: Pediatric cough and cold medications. New England Journal of Medicine, 357, 2321-2324.
11. U.S. Food and Drug Administration, (n.d.). Good clinical practice in FDA-regulated clinical trials. Retrieved February 5, 2008, from http://www.fda. gov/oc/gcp/
12. Wood, A.J.J. (2006). A proposal for radical changes in the drug-approval process. New England Journal of Medicine, 355, 618-623.